CPHI Key Stats
| Income Statement | |
| Revenue TTM | 54.51M |
| Revenue Quarterly YoY Growth | -48.15% |
| EPS Diluted TTM | 0.1015 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | 4.618M |
| Profitability | |
| Gross Profit Margin Quarterly | 11.93% |
| Profit Margin Quarterly | -10.68% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 9.588M |
| Enterprise Value | 9.786M |
| PE Ratio TTM | 2.168 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 0.0646 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.0321 |
| Free Cash Flow | 0.5984M |
| Return on Equity | 3.14% |
CPHI News
- China Pharma Holdings' CEO Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha May 15
- China Pharma Holdings, Inc. Earnings Call scheduled for 8:30 am ET today May 15
- Q1 2013 China Pharma Holdings, Inc. Earnings Release - Time Not Supplied May 15
- China Pharma Holdings, Inc. Reports First Quarter 2013 Financial Results PR Newswire May 15
- CHINA PHARMA HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report May 14
- CPHI to Hold First Quarter of Fiscal Year 2013 Earnings Conference Call on Wedne... May 6
- CHINA PHARMA HOLDINGS, INC. Financials Mar 20
- China Pharma Holdings' CEO Discusses Q4 2012 Results - Earnings Call Transcript Seeking Alpha Mar 15
- China Pharma Holdings, Inc. Earnings Call scheduled for 8:30 am ET today Mar 15
- Q4 2012 China Pharma Holdings, Inc. Earnings Release - Before Market Open Mar 15
CPHI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). China Pharma is down 32.41% over the last year vs S&P 500 Total Return up 31.95%, GlaxoSmithKline up 25.40%, and Tetraphase Pharmaceuticals down 0.25%.
CPHI Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these CPHI related companies
Pro Ratings for CPHI
Pro Report PDF for CPHI
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download CPHI Pro Report PDF
Pro Strategies Featuring CPHI
Did China Pharma make it into our Pro Portfolio Strategies?
CPHI Profile
Exchange: AMEX
Sector: Healthcare
Industry: Drug Manufacturers - Major
Other CPHI Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CPHI | 0.22 | +0.01 | +4.71% | 9.588M |
